Filing Flows › Ionis Pharmaceuticals (IONS) › Recalls, complaints & regulation
Ionis Pharmaceuticals (IONS): clinical trials
Ionis Pharmaceuticals (IONS) beyond its filings: 20 active clinical trials.
Ionis Pharmaceuticals' latest quarter
Ionis Pharmaceuticals, Q2 2026: revenue $268M (-41% year over year), operating margin -38.2%, net loss $115M, operating cash flow $566M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Ionis Pharmaceuticals have?
20 active studies on ClinicalTrials.gov, 12 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.